Reducing risky drinking behaviors among college students using evidence-based strategies.
The College Alcohol Intervention Matrix (College AIM): Adoption and Implementation Across College Campuses
This study is looking at ways to help college students drink less alcohol and stay safe, using a special tool to find the best strategies for campuses, while also talking to those involved to learn about their experiences and challenges.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10880291 on NIH RePORTER |
What this research studies
This research focuses on addressing risky alcohol use among college students, which leads to serious public health issues such as injury and death. The project utilizes the College Alcohol Intervention Matrix (CollegeAIM), a tool that helps colleges identify effective strategies to reduce alcohol consumption on campuses. By evaluating how well these strategies are adopted and implemented, the research aims to enhance the effectiveness of interventions designed to combat risky drinking behaviors among students. Stakeholders involved in the implementation of these strategies will be engaged to understand their experiences and challenges.
Who could benefit from this research
Good fit: Ideal candidates for this research include college students who engage in risky drinking behaviors or are affected by peers who do.
Not a fit: Patients who are not enrolled in college or do not engage in alcohol consumption may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a significant reduction in alcohol-related injuries and deaths among college students.
How similar studies have performed: Previous research has shown success in implementing evidence-based strategies to reduce alcohol consumption in college settings, indicating that this approach has potential.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Helle, Ashley Colleen — University of Missouri-Columbia
- Study coordinator: Helle, Ashley Colleen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.